Flerie DB:1NP1 Stock Report

Last Price

€3.99

Market Cap

€319.8m

7D

-2.8%

1Y

n/a

Updated

01 Jan, 2025

Data

Company Financials

Flerie AB (publ)

DB:1NP1 Stock Report

Market Cap: €319.8m

1NP1 Stock Overview

A venture capital firm specializing in early-stage investments. More details

1NP1 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

My Notes

Capture your thoughts, links and company narrative

Flerie AB (publ) Competitors

PharmaSGP Holding

XTRA:PSG

€299.8m

Pierrel

DB:2FJ0

€92.8m

MPH Health Care

DB:93M1

€95.9m

Apontis Pharma

XTRA:APPH

€83.7m

Price History & Performance

Summary of share price highs, lows and changes for Flerie
Historical stock prices
Current Share Price	SEK 3.99
52 Week High	SEK 4.23
52 Week Low	SEK 2.08
Beta	0
1 Month Change	1.40%
3 Month Change	10.39%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.98%

Recent News & Updates

Recent updates

Shareholder Returns

	1NP1	DE Pharmaceuticals	DE Market
7D	-2.8%	1.7%	0.3%
1Y	n/a	-16.3%	6.9%

Return vs Industry: Insufficient data to determine how 1NP1 performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1NP1 performed against the German Market.

Price Volatility

Is 1NP1's price volatile compared to industry and market?
1NP1 volatility
1NP1 Average Weekly Movement	4.5%
Pharmaceuticals Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 1NP1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 1NP1's weekly volatility has decreased from 22% to 5% over the past year.

About the Company

Founded	Employees	CEO	Website
2011	n/a	Ted Fjallman	www.flerie.com

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.

Flerie AB (publ) Fundamentals Summary

How do Flerie's earnings and revenue compare to its market cap?
1NP1 fundamental statistics
Market cap	€319.78m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 1NP1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1NP1 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

Jan 22, 2025

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 1NP1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/01 02:04
End of Day Share Price	2024/12/30 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Flerie AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution